I use genomics, bioinformatics and population-scale epidemiology to identify aging and mitochondrial biomarkers, quantify environmental and clinical risk, and build predictive models for cardiometabolic, hematologic/oncologic and women’s health outcomes using biobank data, proteomics and imaging-derived measures.